Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer

This study has been terminated.
National Cancer Institute (NCI)
Information provided by:
Case Comprehensive Cancer Center Identifier:
First received: January 9, 2004
Last updated: July 21, 2011
Last verified: July 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2005
  Primary Completion Date: September 2004 (Final data collection date for primary outcome measure)